Suda I, Takahashi H
Toxicol Appl Pharmacol. 1986 Jan;82(1):45-52. doi: 10.1016/0041-008x(86)90436-9.
Biotransformation of methyl mercury in rats was studied by enhancing or inhibiting its biotransformation with various procedures. A new sensitive method developed to determine specifically inorganic mercury in the presence of organic mercury was used. Biotransformation was enhanced by treating the rat with phenylhydrazine. The increase of inorganic mercury was highest (four to five times) and rapid in the spleen. Inhibited biotransformation of methyl mercury was observed in splenectomized rats. The inorganic portion of total mercury in the macrophage-rich fraction of spleen cells was clearly higher than that in unfractionated spleen cells. The biotransformation of methyl mercury was inhibited by treating the rat with carrageenan, a well-known substance blocking macrophage function. These results suggest that the spleen is an important site for the formation of inorganic mercury, and that the macrophage participates in this biotransformation.
通过各种程序增强或抑制大鼠体内甲基汞的生物转化,对其进行了研究。使用了一种新开发的灵敏方法,该方法可在有机汞存在的情况下特异性地测定无机汞。用苯肼处理大鼠可增强生物转化。脾脏中无机汞的增加最高(四到五倍)且迅速。在脾切除的大鼠中观察到甲基汞的生物转化受到抑制。富含巨噬细胞的脾细胞部分中总汞的无机部分明显高于未分级的脾细胞。用角叉菜胶(一种众所周知的阻断巨噬细胞功能的物质)处理大鼠可抑制甲基汞的生物转化。这些结果表明,脾脏是无机汞形成的重要部位,并且巨噬细胞参与了这种生物转化。